Network Biology and Proteomics Image Dr Alexander von Kriegsheim - HTPU and Mass Spectrometry Facility Manager\n Research in a NutshellMy research group aims to identify potential weaknesses in the otherwise robust signalling networks of cancer cells which can be exploited for therapeutic intervention. We specifically focus on the initiating events in cancer establishment as well as the events triggering the spread of cancer throughout the body.We commonly use mass spectrometry methods, such as interaction, expression, exosome/secretion and PTM proteomics to initially generate signalling networks. Subsequently we use this integrated information to generate new and testable hypotheses. This unbiased data which we use in combination with mathematical modelling can explain unintuitive cellular behaviours. Currently, we are focusing on how hydoxylations can regulate tumour initiation and how the modification by ISG15, a small ubiquitin-like protein modifier, promotes tumour cell invasion and metastasis.In addition, we collaborate with groups worldwide and across all disciplines which require accurate and quantitative mass spectrometry data sets to further their research. Research Programme Image People Alexander von KriegsheimGroup LeaderJair Marques JuniorLab ManagerAgata MakarPost-doctoral Research AssociateChinmayi PednekarMass Spectrometry Research OfficerNajib AbualethamPhD StudentChartinun ChutoePhD StudentAbu Zaid KhanPhD StudentMab HabeebPhD StudentHaya Al SiyabiPhD StudentManal AlharbiPhD StudentContactAlex.VonKriegsheim@ed.ac.uk Alex von Kriegsheim - Research Information CollaborationsCormac Taylor (UCD Dublin)Boris Kholodenko (Systems Biology Ireland)Partners and FundersBreast Cancer NOW/project/2014-2018/190,000Wellcome Trust/ISSF2/2016/70,000Carnegie TrustScientific ThemesHypoxia signalling, ISG15 regulated networks, cell migration and invasionTechnology ExpertiseMass spectrometry, systems biology, signalling network biology This article was published on 2024-09-23